drugset / Trial / NCT05356793

The Efficacy Of SCH1 In The Treatment Of Acute Infectious Conjunctivitis

NCT05356793 ↗

Phase 2 Completed 30 enrolled Sacsh
RandomizedParallel-groupTriple-blindTreatment

Summary

The objective of this study is to evaluate the efficacy of Sasch1, a novel anti-infective eyedrop, in the treatment of acute infectious conjunctivitis.

Timeline

Start
2021-03-01
Primary completion
2022-03-28
Completion
2022-03-28

Drugs

EvaluationDrugModalityDoseRoute
Subject SCH-1 Unknown — —

Indications